LY4086940
A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes
Eli Lilly · Phase 2 · Not yet recruiting · Enrollment 460
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| LY4086940 Dose 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY4086940 Dose 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY4086940 Dose 3, Titration Schedule A | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY4086940 Dose 3, Titration Schedule B | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY4086940 Dose 4 | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY4086940 Dose 5 | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY4086940 Dose 6, Titration Schedule A | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY4086940 Dose 6, Titration Schedule B | Obesity or overweight | n/r | n/r | n/r | n/r |
| LY4086940 Dose 6, Titration Schedule C | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |